LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

ADispell

Fast-track development of novel drugs for an unmet medical need - Alzheimer\'s disease - with rapid payback on investment.

Get a Demo and See the Full Profile

Get a demo today to see profiles of ADispell plus 6131 other startups.

Learn More About ADispell

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More